These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27322426)

  • 21. Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.
    García-Rocha R; Moreno-Lafont M; Mora-García ML; Weiss-Steider B; Montesinos JJ; Piña-Sánchez P; Monroy-García A
    Cytokine; 2015 Dec; 76(2):382-390. PubMed ID: 26343835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
    Ma D; Niederkorn JY
    Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of immune evasion of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Morandi F; Bocca P; Gambini C; Ferrone S; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):155-61. PubMed ID: 15923080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of fibronectin 1 attenuates ATRA-induced inhibition of cell migration and invasion in neuroblastoma cells.
    Tan X; Gong W; Chen B; Gong B; Hua Z; Zhang S; Chen Y; Li Q; Li Z
    Mol Cell Biochem; 2021 Oct; 476(10):3601-3612. PubMed ID: 34024029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion.
    Panchoo M; Lacko A
    Biochem Biophys Res Commun; 2018 Jan; 495(1):614-620. PubMed ID: 29128352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
    Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
    Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA‑451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.
    Liu G; Xu Z; Hao D
    Mol Med Rep; 2016 Mar; 13(3):2253-60. PubMed ID: 26783235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHD5 inhibits metastasis of neuroblastoma.
    Laut AK; Dorneburg C; Fürstberger A; Barth TFE; Kestler HA; Debatin KM; Beltinger C
    Oncogene; 2022 Jan; 41(5):622-633. PubMed ID: 34789839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
    Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
    Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.
    Gross N; Beck D; Favre S
    Cancer Res; 1990 Dec; 50(23):7532-6. PubMed ID: 1701347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.
    Bhoopathi P; Pradhan AK; Bacolod MD; Emdad L; Sarkar D; Das SK; Fisher PB
    Oncogene; 2019 Oct; 38(41):6781-6793. PubMed ID: 31406249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-24 inhibits cell migration and invasion in the neuroblastoma cell line SH-SY5Y.
    Zhuo B; Wang R; Zhang H; Qin H; Yin Y; Shi Y
    Oncol Rep; 2013 Dec; 30(6):2749-54. PubMed ID: 24084981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroblastoma-induced inhibition of dendritic cell IL-12 production via abrogation of CD40 expression.
    Walker SR; Redlinger RE; Barksdale EM
    J Pediatr Surg; 2005 Jan; 40(1):244-9; discussion 249-50. PubMed ID: 15868592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.
    Zhang L; Yeger H; Das B; Irwin MS; Baruchel S
    Neoplasia; 2007 Jan; 9(1):36-46. PubMed ID: 17325742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
    Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
    Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
    Morandi F; Chiesa S; Bocca P; Millo E; Salis A; Solari M; Pistoia V; Prigione I
    Neoplasia; 2006 Oct; 8(10):833-42. PubMed ID: 17032500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
    Shurin GV; Shurin MR; Bykovskaia S; Shogan J; Lotze MT; Barksdale EM
    Cancer Res; 2001 Jan; 61(1):363-9. PubMed ID: 11196188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.